Abstract:OBJECTIVE: The objective of this study was to evaluate whether blastocyst culture of human suboptimal embryos could help for embryo selection and improve clinical outcomes.DESIGN: Retrospective study.MATERIALS AND METHODS: The inclusion criteria were patients who had only suboptimal embryos (all embryos ≤6-cell or embryo fragments >10%) on Day 3. In Day 3 transfer group, embryos were selected and transferred on Day 3. In blastocyst culture group, embryos were cultured to Day 5 and transferred if reached blastocyst stage. Embryos were cultured in Vitrolife G5 series culture media at 37.5°C, 6% CO2, 5% O2. The mean age of patients was not significantly different between the groups (32.3 VS. 32.0 years). Clinical pregnancy, ongoing pregnancy and implantation rate were compared between the groups using χ Test.RESULTS: In Day 3 transfer group, 241 embryos of 114 patients (2.1 embryos /patient) were transferred, 59 were implanted (24.5%), clinical pregnancy was confirmed in 44 patients (38.6%), and ongoing pregnancy was defined in 40 patients (35.1%; miscarriage=1, ectopic pregnancy=3). In blastocyst culture group, 421 embryos of 106 patients were cultured to Day 5, 88 reached blastocyst (20.9%), and 18 blastocysts were scored ≥ 3BB (Gardener's grading criteria) (4.3%). Fifty-seven cycles (53.8%) were cancelled because of unavailability of blastocysts. Eighty-four blastocysts of 49 patients (1.7 embryos /patient) were transferred, 15 were implanted (17.9%), and clinical pregnancy and ongoing pregnancy was confirmed in 12 patients (11.3% per oocyte retrieval, 24.5% per embryo transfer). The mean number of transferred embryos (P=0.001), clinical pregnancy and ongoing pregnancy rate per oocyte retrieval (P<0.001) were significantly higher in Day 3 transfer group.CONCLUSIONS: Human embryos with suboptimal morphology showed limited developmental potential. Extended in vitro culture has more adverse stress on them, which can lead to developmental arrest. Blastocyst culture of suboptimal embryos does not improve clinical outcomes. OBJECTIVE: The objective of this study was to evaluate whether blastocyst culture of human suboptimal embryos could help for embryo selection and improve clinical outcomes. DESIGN: Retrospective study. MATERIALS AND METHODS: The inclusion criteria were patients who had only suboptimal embryos (all embryos ≤6-cell or embryo fragments >10%) on Day 3. In Day 3 transfer group, embryos were selected and transferred on Day 3. In blastocyst culture group, embryos were cultured to Day 5 and transferred if reached blastocyst stage. Embryos were cultured in Vitrolife G5 series culture media at 37.5°C, 6% CO2, 5% O2. The mean age of patients was not significantly different between the groups (32.3 VS. 32.0 years). Clinical pregnancy, ongoing pregnancy and implantation rate were compared between the groups using χ Test. RESULTS: In Day 3 transfer group, 241 embryos of 114 patients (2.1 embryos /patient) were transferred, 59 were implanted (24.5%), clinical pregnancy was confirmed in 44 patients (38.6%), and ongoing pregnancy was defined in 40 patients (35.1%; miscarriage=1, ectopic pregnancy=3). In blastocyst culture group, 421 embryos of 106 patients were cultured to Day 5, 88 reached blastocyst (20.9%), and 18 blastocysts were scored ≥ 3BB (Gardener's grading criteria) (4.3%). Fifty-seven cycles (53.8%) were cancelled because of unavailability of blastocysts. Eighty-four blastocysts of 49 patients (1.7 embryos /patient) were transferred, 15 were implanted (17.9%), and clinical pregnancy and ongoing pregnancy was confirmed in 12 patients (11.3% per oocyte retrieval, 24.5% per embryo transfer). The mean number of transferred embryos (P=0.001), clinical pregnancy and ongoing pregnancy rate per oocyte retrieval (P<0.001) were significantly higher in Day 3 transfer group. CONCLUSIONS: Human embryos with suboptimal morphology showed limited developmental potential. Extended in vitro culture has more adverse stress on them, which can lead to developmental arrest. Blastocyst culture of suboptimal embryos does not improve clinical outcomes.

Optimal number of high-quality cleavage-stage embryos for extended culture to blastocyst-stage for transfer in women 38 years and older

Clinical outcomes after elective double-embryo transfer in frozen cycles for women of advanced maternal age

Clinical outcomes after elective double-embryo transfer in frozen cycles for women of advanced maternal age A retrospective cohort study

Blastocyst Culture of Human Suboptimal Embryos Does Not Improve Clinical Outcomes

[Study of the Best Embryo Transfer Strategy in Frozen-Thawed Embryo Transfer Cycle].

Frozen Versus Fresh Single Blastocyst Transfer in Ovulatory Women: a Multicentre, Randomised Controlled Trial.

A comparison of embryo culture strategies for women of advanced age with four or fewer available D3 embryos: a single centre retrospective analysis of 556 patients

Should all embryos be cultured to blastocyst for advanced maternal age women with low ovarian reserve: a single center retrospective study.

Comparison of blastocyst transfer to day 3 transfer with assisted hatching in the older patient

Improving the clinical outcomes by extended culture of day 3 embryos with low blastomere number to blastocyst stage following frozen–thawed embryo transfer

Comparison of frozen-thaw blastocyst transfer strategies in women aged 35–40 years: a retrospective study

Clinical Outcomes for Day 3 Double Cleavage-Stage Embryo Transfers Versus Day 5 or 6 Single Blastocyst Transfer in Frozen–thawed Cycles: a Retrospective Comparative Analysis

Impact of fresh cleavage-stage embryo transfer policy on pregnancy outcomes in women aged 35-38 years

Single versus double blastocyst transfer in first and second frozen-thawed embryo transfer cycle in advance-aged women: a two-center retrospective cohort study

Disposition of embryos from women who only produced morphologically poor embryos on day three

One Fresh Cleavage-Stage Single Embryo Transfer (SET) Plus One Frozen-Thawed Blastocyst-Stage SET or One Fresh Cleavage-Stage Double Embryo Transfer? A Retrospective Matched Cohort Study.

Blastocyst Transplantation Strategies in Women of Different Ages

Effect of sequential cleavage and blastocyst embryo transfer compared to single cleavage stage embryo transfer on assisted reproductive technology outcome: An RCT

Influence of Decreasing the Number of Embryos Transferred on Pregnancy Outcomes in Advanced Age Women Undergoing in Vitro Fertilization-Embryo Transfer

The Valuable Reference of Live Birth Rate in the Single Vitrified-Warmed BB/BC/CB Blastocyst Transfer: the Cleavage-Stage Embryo Quality and Embryo Development Speed

Extended embryo culture in human assisted reproduction treatments